Antoine Petitcollin (A Petitcollin)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Patients With Inflammatory Bowel Disease

Sentinel Lymph Node

Top Venues

Antimicrobial agents and chemotherapy

European journal of clinical pharmacology

Alimentary pharmacology & therapeutics

Clinical pharmacokinetics

CHIC de Bigorre

Université de Rennes 1 Faculté de Médecine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHIC de Bigorre Nov 04 2019

France

Responsable :: Pharmaco-toxicologie

CHRU de Rennes

France

Assistant Hospitalier Universitaire :: Laboratoire de Pharmacologie Biologique

Université de Rennes 1 Faculté de Médecine

France

Assistant Hospitalier Universitaire :: Inserm CIC-P 1414, équipe Modélisation PK et PK-PD

Education History

Université de Rennes 1 Faculté de Médecine

France

MSC

Publications

Antoine Petitcollin, N Azzopardi, J Y Pierga, D Ternant, I Navarro-Teulon, C Desvignes, M A Mouret-Reynier, B Coudert, G Paintaud
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer. European journal of clinical pharmacology 77 (12) (2021)
Antoine Petitcollin, Amina Bensalem, Marie-Clémence Verdier, Camille Tron, Florian Lemaitre, Gilles Paintaud, Eric Bellissant, David Ternant
Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review. Clinical pharmacokinetics 59 (1) (2021)
Camille Lucidarme, Antoine Petitcollin, Charlène Brochard, Laurent Siproudhis, Marie Dewitte, Amandine Landemaine, Eric Bellissant, Guillaume Bouguen
Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring. Alimentary pharmacology & therapeutics 49 (2) (2019)
Antoine Petitcollin, C Boglione-Kerrien, C Tron, S Nimubona, S Lalanne, F Lemaitre, E Bellissant, M-C Verdier
Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose. Antimicrobial agents and chemotherapy 61 (11) (2017)